Tax Smart Real Estate Investors

Disguised Sales in Real Estate: How Refinances Can Trigger Taxes (Avoid This!)

The episode tackles a subtle but costly tax pitfall in real‑estate partnerships: the "disguised sale" that can arise when a general partner contributes property and then receives cash‑out refinancing proceeds or other distributions shortly thereafter. While cash‑out loans are generally tax‑free for direct owners, partnership rules treat certain cash returns as deemed sales, potentially triggering capital‑gains tax. The hosts walk through the mechanics of partnership basis—how contributions, income allocations, and depreciation build a partner’s outside basis, and how distributions, including debt pay‑downs, reduce it. They explain that under IRC 707A and the 704(b) allocation rules, any cash returned to the contributing partner within a two‑year window is presumed to be a sale, unless the distribution qualifies as a "qualified liability" under the safe‑harbor provision. Proper allocation of partnership debt under §752 is critical to staying within that safe harbor. A concrete scenario illustrates the risk: a GP contributes a $2 million multifamily asset with a $500 k tax basis, the partnership refinances and returns $1.5 million to the GP within 18 months. The IRS would treat that as a disguised sale, imposing tax on roughly $1 million of gain. However, if the partnership can demonstrate that the cash flow is tied to a qualified liability—debt directly attributable to the contributed property and allocated for at least two years—the transaction falls within the safe harbor and avoids the deemed‑sale treatment. The takeaway for syndicators and large‑scale investors is clear: partnership tax planning must extend beyond simple cash‑flow modeling. Engaging a tax specialist familiar with §§707A, 704(b), and 752 is essential to structure contributions, refinances, and distributions that stay inside the safe harbor, thereby protecting partners from unexpected capital‑gains liabilities and preserving deal economics.